Mydecine Innovations Group Inc. (MYCO.NE)

0.5300 0.0000 (0.00%) At close: 03:59PM EDT

Mydecine Innovations Group Inc.

789 West Pender Street
Suite 810
Vancouver, BC V6C 1H2
Canada

https://www.mydecine.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Joshua Bartch	Co-Founder, CEO, Pres & Chairman	392.6k	N/A	1987
Mr. Robert Roscow M.A.	Co-Founder, Chief Scientific Officer & Director	398.56k	N/A	N/A
Mr. Damon Michaels	Co-Founder & COO	405.06k	N/A	N/A
Mr. Sanford M. Stein	Chief Compliance Officer, Gen. Counsel & Corp. Sec.	250.03k	N/A	N/A
Dr. Rakesh Jetly FRCPC, M.D.	Chief Medical Officer	261k	N/A	N/A
Mr. John Charles Ross CA, CPA, M.B.A.	Chief Financial Officer	N/A	N/A	1958
Morgan Kervitsky	Director of Marketing	N/A	N/A	N/A
Mr. Michel Rudolphie	Pres of the European Operations	N/A	N/A	N/A
Mr. William Cook	Interim CEO & Technical Director of Mindleap Health Inc.	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates hemp farm in Pottus, Texas. Mydecine Innovations Group Inc. has a partnership with Leiden University Medical Center; Royal Ottawa Mental Health Centre; LeadGen Labs to support psychedelic drug development; and Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Corporate Governance

Mydecine Innovations Group Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.